Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Depreciation & Amortization (CF) (2016 - 2025)

BioCorRx's Depreciation & Amortization (CF) history spans 15 years, with the latest figure at $71987.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 972.03% year-over-year to $71987.0; the TTM value through Sep 2025 reached $181810.0, up 576.96%, while the annual FY2024 figure was $33145.0, 23.64% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $71987.0 at BioCorRx, roughly flat from $71977.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $71987.0 in Q3 2025 and bottomed at $6665.0 in Q1 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $6863.0 (2021), against an average of $16870.4.
  • The largest annual shift saw Depreciation & Amortization (CF) plummeted 65.25% in 2021 before it soared 972.04% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $6863.0 in 2021, then decreased by 0.01% to $6862.0 in 2022, then dropped by 2.14% to $6715.0 in 2023, then surged by 93.64% to $13003.0 in 2024, then surged by 453.62% to $71987.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Depreciation & Amortization (CF) are $71987.0 (Q3 2025), $71977.0 (Q2 2025), and $24843.0 (Q1 2025).